New radiation therapy shows promise for inoperable liver cancer
NCT ID NCT05797870
First seen Mar 20, 2026 · Last updated May 25, 2026 · Updated 9 times
Summary
This study tests a radioactive treatment called 188Re-SSS lipiodol for people with liver cancer that cannot be surgically removed. The treatment delivers radiation directly to the tumor through the liver's blood supply. The goal is to see how well it shrinks tumors within 6 months. The study involves 16 adults with good physical function and limited liver tumor burden.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA NON-RESECTABLE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre de Lutte contre le Cancer Eugène Marquis
Rennes, Brittany Region, 35042, France
Conditions
Explore the condition pages connected to this study.